Skip Navigation

JNCI Journal of the National Cancer Institute 2006 98(16):1095; doi:10.1093/jnci/djj355
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Japanese Translation
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2006.

IN THIS ISSUE

The first 10% of the full text of this article appears below.

Risk of Serious Side Effects of Breast Cancer Chemotherapy

Many clinical trials are not designed to accurately estimate the risks of important side effects posed by new treatments. To better assess the risks of serious adverse effects experienced by women with breast cancer treated with chemotherapy outside of clinical trials, Hassett et al. (p. 1108) analyzed medical insurance claims of matched breast cancer patients who did or did not receive chemotherapy but who were otherwise very similar. Chemotherapy recipients were more likely than non-recipients to experience each of eight serious side effects of chemotherapy, and the frequencies of several side effects were higher . . . [Full Text of this Article]

Effects of Bortezomib on Human Neuroblastoma

Modeling Extravascular Transport and Activity of Drugs

Effect of Finasteride on Sensitivity of the PSA Test

Initial Local Therapy Use In Lower-Risk Prostate Cancer

Carbonated Soft Drinks and Esophageal Adenocarcinoma


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?